Showing results (741-750 of 798) with videos related to

Sort By:
Pageof 80
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 26, 2024
Canada's provincial COVID-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responsesYiqing Xia, Jorge Luis Flores Anato, Caroline Colijn, et al.
Pediatric Cardiology|January 15, 2025
Racial and Educational Isolation are Associated with Worse Outcomes in Congenital Heart DiseaseMeredith Sooy-Mossey, Neeta J Sethi, Hillary Mulder, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2012
Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analysesYasong Lu, David Riddell, Eva Hajos-Korcsok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor ProgressionXiaoming Li, H Michael Shepard, Jessica A Cowell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2024
FDA Approval Summary: Capecitabine Labeling Update under Project RenewalSundeep Agrawal, Clara Lee, William F Pierce, et al.
Research Square|November 22, 2024
Racial and Educational Isolation are Associated with Worse Outcomes in Congenital Heart DiseaseMeredith Sooy-Mossey, Neeta J Sethi, Hillary Mulder, et al.
ACS Synthetic Biology|December 20, 2014
A multiplexed transcription activator-like effector system for detecting specific DNA sequencesAli Honarmand, Robert Mayall, Iain George, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
The <i>TECTB-C225Y</i> Variant Causing Autosomal Dominant Deafness in a Nicaraguan Family Enhances Sensitivity to Noise-Induced Hearing Loss in MiceEvan B Hale, Barbara Vona, Richard J Goodyear, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast CancerPreeti Narayan, Christy L Osgood, Harpreet Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2020
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast CancerSakar Wahby, Lola Fashoyin-Aje, Christy L Osgood, et al.
Pageof 80